Corssmit EP, Heyligenberg R, Endert E, et al. - Acute effects of interferon-alpha administration on thyroid hormone metabolism in healthy men. J Clin Endocrinol Metab, 1995, 80, 3140-3144.
Koh LKH, Greenspan FS, Yeo PPB. - Interferonalpha induced thyroid dysfunction: three clinical presentations and review of the literature. Thyroid, 1997, 7, 891-896.
Fentiman IS, Thomas BS, Balkwill FR, et al. - Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet, 1985, 1, 1166.
Nadeem A, Hussain MM, Aslam M, et al. - Alpha-Interferon induced Thyroid Dysfonction in Patients with chronic hepatitis C. Hepat Mon, 2010, 10, 132-140.
Papo T. - Interféron alpha et auto-immunité. Rev Med Interne, 2002, 23, 501s-510s.
Watanabe U, Hashimoto E, Hisamitsu T et al. - The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol, 1994, 89, 399-403.
Wong V, Fu AX, George J, et al. - Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis. Clin Endocrinol, 2002, 56, 793-798.
Binaghi M, Lévy C, Douvin C, et al. - Ophtalmopathie de Basedow sévère liée à l'interféron alpha. J Fr Ophtalmol, 2002, 25, 412-415.
Mandac JC, Chaudhry S, Sherman KE, et al. - The Clinical and Physiological Spectrum of Interferon-Alpha Induced Thyroiditis : Toward a New Classification. Hepatology, 2006, 43, 661-672.
Marcellin P, Pouteau M, Benhamou JP. - Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol, 1995, 22, 364-369.
Koizumi S, Mashio Y, Mizuo H, et al. - Graves' hyperthyroidism following transient thyrotoxicosis during interferon therapy for chronic hepatitis type C. Intern Med,1995, 34, 58-60.
Oppenheim Y, Kim G, Nan Y, et al. - The Effects of Alpha Interferon on the Development of Autoimmune Thyroiditis in the NOD H2h4 Mouse. Clin Dev Immunol, 2003, 10, 161-165.
Gelu-Simeon M, Burlaud A, Young J, et al. - Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C. World J Gastroenterol, 2009, 15, 328-333.
Kabbaj N, Guedira MM, El Atmani H, et al. - Thyroid disorders during interferon alpha therapy in 625 patients with chronic hepatitis C : a prospective cohort study. Ann Endocrinol, 2006, 67, 343-347.
Bini EJ, Mehandru S. - Incidence of thyroid dysfunction during Interferon Alfa-2b and Ribavirin therapy in men with chronic hepatitis C. Arch Intern Med, 2004, 164, 2371-2376.
Maiga, I, Valdes Socin HG, Delwaide, et al. - Dysthyroïdies iatrogènes. Abstract book. Annales d'Endocrinologie. 31ème Congrès de la Société Française d'Endocrinologie, Lyon 5-8 novembre 2014. http://hdl.handle.net/2268/174089.Consultation du 19 décembre 2014.
Okanoue T, Sakamoto S, Itoh Y, et al. - Side effects of high-dose interferon therapy for chronic hepatitis C, J Hepatol, 1996, 25, 283-291.
